10 Dec 2024
// BUSINESSWIRE
11 Nov 2024
// BUSINESSWIRE
24 Oct 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
01 1MIRVETUXIMAB SORAVTANSINE-GYNX
01 1IMMUNOGEN INC
01 1INJECTABLE;INJECTION
01 1100mg/20mL single-dose vial
01 1USA
Regulatory Info :
Registration Country : USA
MIRVETUXIMAB SORAVTANSINE-GYNX
Dosage Form : INJECTABLE;INJECTION
Brand Name : ELAHERE
Dosage Strength : 100mg/20mL single-dose...
Packaging :
Approval Date :
Application Number : 761310
Regulatory Info :
Registration Country : USA
LOOKING FOR A SUPPLIER?